InvestorsHub Logo
Followers 2
Posts 253
Boards Moderated 0
Alias Born 06/04/2007

Re: surf1944 post# 83

Tuesday, 10/28/2008 3:36:53 PM

Tuesday, October 28, 2008 3:36:53 PM

Post# of 1874
Hi Surf,

It was interesting to see this trial start so soon after ASCO.

First line treatment in NSCLC is another high visibility target for Reolysin. The stable of potential indications for Reolysin continues to grow.

onco_investor

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCY News